No Grouping Authors/Creators

AMIS Final Report. (2021) Antimicrobials In Society Programme

Rebuilding a Resilient Britain: Data and Evaluation Areas of Research Interest across Government. (2021) Boaz, Annette; Oliver, Kathryn; Cuccato, Giulia; Dashwood, Cameron

Experiences of COVID-19 and Perspectives on Vaccination: Key Findings from a Survey in Two Informal Settlements in Freetown. (2021) Conteh, Abu; Enria, Luisa; Klingel, Andrea; Lees, Shelley; Macarthy, Joseph; Mansaray, Anthony; Roberts, Chrissy; Tarawally, Ansumana

A rapid assessment of the gender-based violence (GBV) situation and response in Cabo Delgado, Mozambique. (2021) D'Odorico, Giulia; Hossain, Mazeda; Jamal, Elisa; Scarpassa do Prado, Danielle; Roberts, Colleen; Palmer, Jennifer

Science Advice in the UK. (2021) Hopkins, Anna; Foxen, Sarah; Oliver, Kathryn; Costigan, Gavin

Exploring the implementation of disability-inclusive WASH policy commitments in Svay Ring and Kampong Chhnang Province, Cambodia. Learning Briefing Note 3. (2021) Huggett, Chelsea; Has, Rithysangharith; Pheng, Pharozin; Wilbur, Jane

Are the rights of people with disabilities included in international guidance on WASH during the COVID-19 pandemic? Briefing note. (2021) Huggett, Chelsea; Scherer, Nathaniel; Pheng, Pharozin; Rahman, Mahfuj-ur; Wilbur, Jane

Cambodia and Bangadesh Water, Sanitation and Hygiene Policy Analysis: Using the EquiFrame to understand how WASH policies and program documents capture the rights of people with disabilities and women and girls. Briefing note 2. (2021) Huggett, Chelsea; Scherer, Nathaniel; Pheng, Pharozin; Rahman, Mahfuj-ur; Wilbur, Jane

Brexit and the migrant care workforce: Future policy directions. Findings from the second round of Delphi Surveys of UK experts. (2021) Hussein, Shereen; Turnpenny, Agnes

The co-production of research between academics, NGOs and communities in humanitarian response: A practice guide. (2021) Lokot, Michelle; Wake, Caitlin

Seasonal Malaria Chemoprevention in Guinea in 2020: coverage survey results. (2021) Loua, Kovana Marcel; Milligan, Paul

Scoping report for the UK Vaccine Network: Options for investment in vaccines and vaccine technology for infectious diseases with epidemic potential. (2021) Noad, Rob; Ismail, Sharif; Simpson, Karl; Scott, Anthony

How can we transfer service and policy innovations between health systems? (2021) Nolte, Ellen; Groenewegen, Peter

Rebuilding a Resilient Britain: Evidence Gaps and Knowledge Exchange Opportunities. (2021) Oliver, Kathryn; Boaz, Annette; Cuccato, Giulia; Dashwood, Cameron

Policy and stakeholder analysis to inform advocacy on drowning reduction among fishers in southern Lake Victoria, Tanzania: Report. (2021) Plummer, Mary Louisa; Mashauri, Emma; Moshi, Amen; Durrance-Bagale, Anna; Ayieko, Philip; Howard, Natasha

Study protocol: Evaluation of the Mamás del Río programme - a community-based, maternal and neonatal health intervention in Rural Amazonian Peru. (2021) Reinders, Stefan; Blas, Magaly M; Lange, Isabelle L; Ronsmans, Carine

The forgotten population? A call to invest in adolescent well-being in humanitarian and fragile settings. (2021) Singh, Neha; DeJong, Jocelyn; Popple, Kimberley; Undie, Chi-Chi; El Masri, Rozane; Bakesiima, Ritah; Calderon-Jaramillo, Mariana; Peprah, Ellen; Naseri, Saha; Cornier, Nadine; Blanchet, Karl

Addressing antibiotic use: insights from social science around the world. (2021) Tompson, Alice C; Chandler, Clare IR

The Science in the Middle: Middle Level Theory in International Development Evaluation. (2021) Vigneri, Marcella

Background document on the inactivated vaccine Sinovac-CoronaVac against COVID-19. (2021) WHO SAGE Working Group on COVID-19 Vaccinations picture_as_pdf

Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac. (2021) WHO SAGE Working Group on COVID-19 Vaccinations

AZD1222 vaccine against COVID-19 developed by Oxford University and Astra Zeneca: Background paper. (2021) WHO SAGE Working Group on COVID-19 Vaccines

Background document on the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19. (2021) WHO SAGE Working Group on COVID-19 Vaccines

Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca. (2021) WHO SAGE Working Group on COVID-19 Vaccines

Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing. (2021) WHO SAGE Working Group on COVID-19 Vaccines

Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm. (2021) WHO SAGE Working Group on COVID-19 Vaccines picture_as_pdf

Learning brief: Including people with disabilities, older adults, and their caregivers in COVID-19 prevention programmes. (2021) Wapling, Lorraine

Learning brief: Strengthening the monitoring and evaluation of COVID-19 prevention programmes. (2021) White, Sian

Learning brief: Coordinating and managing information during the COVID-19 pandemic. (2021) White, Sian; Collin, Claire

Background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine. (2021) World Health Organisation SAGE Working Group on COVID-19 Vaccine

Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine. (2021) World Health Organisation SAGE Working Group on COVID-19 Vaccine; Wilder-smith, Annelies; Hombach, Joachim; Marti, Melanie; O'Brien, Katherine